We are live on ! Find out more
FTWA

Fifth Third Wealth Advisors Portfolio holdings

AUM $3.58B
1-Year Est. Return 34.55%
This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+34.55%
3 Year Est. Return
+102.4%
5 Year Est. Return
10 Year Est. Return
AUM
$1.84B
AUM Growth
+$212M
Cap. Flow
+$186M
Cap. Flow %
10.1%
Top 10 Hldgs %
45.28%
Holding
774
New
76
Increased
325
Reduced
206
Closed
52

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$1.74M
2
LEN icon
Lennar Class A
LEN
+$1.52M
3
ESTC icon
Elastic
ESTC
+$1.26M
4
DIS icon
Walt Disney
DIS
+$1.18M
5
OKE icon
Oneok
OKE
+$951K

Sector Composition

Rank Sector Weight
1 Technology 18.67%
2 Financials 8%
3 Consumer Discretionary 7.23%
4 Communication Services 5.51%
5 Industrials 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPG
351
DELISTED
Interpublic Group of Companies
IPG
$441K 0.02%
15,723
+8,819
+128% +$263K
DLR icon
352
Digital Realty Trust
DLR
$73.7B
$440K 0.02%
2,483
+49
+2% +$8.69K
TDY icon
353
Teledyne Technologies
TDY
$30.4B
$440K 0.02%
948
+126
+15% +$58.7K
COR icon
354
Cencora
COR
$60.3B
$440K 0.02%
1,958
+206
+12% +$48.4K
NEM icon
355
Newmont
NEM
$98.2B
$440K 0.02%
11,816
-2,106
-15% -$96K
CBRE icon
356
CBRE Group
CBRE
$40.8B
$440K 0.02%
3,348
+513
+18% +$67.2K
CI icon
357
Cigna
CI
$76.6B
$439K 0.02%
1,590
-5
-0.3% -$1.59K
ACM icon
358
Aecom
ACM
$9.07B
$437K 0.02%
4,093
+385
+10% +$42K
NBIX icon
359
Neurocrine Biosciences
NBIX
$17.7B
$434K 0.02%
3,181
ETR icon
360
Entergy
ETR
$54.1B
$430K 0.02%
5,676
+802
+16% +$57.9K
FAST icon
361
Fastenal
FAST
$54B
$426K 0.02%
11,862
+736
+7% +$28.7K
WEC icon
362
WEC Energy
WEC
$37.7B
$426K 0.02%
4,531
+42
+0.9% +$4.07K
JLL icon
363
Jones Lang LaSalle
JLL
$15.1B
$426K 0.02%
1,681
+32
+2% +$8.53K
ITT icon
364
ITT
ITT
$17.5B
$425K 0.02%
2,978
-34
-1% -$5.09K
JEF icon
365
Jefferies Financial Group
JEF
$12.9B
$425K 0.02%
5,421
FHN icon
366
First Horizon
FHN
$12.1B
$419K 0.02%
20,826
-863
-4% -$16.2K
DOC icon
367
Healthpeak Properties
DOC
$15.4B
$419K 0.02%
20,670
+7,941
+62% +$172K
UTHR icon
368
United Therapeutics
UTHR
$26.3B
$418K 0.02%
1,184
-304
-20% -$112K
ZBRA icon
369
Zebra Technologies
ZBRA
$12.4B
$418K 0.02%
1,081
+263
+32% +$102K
DT icon
370
Dynatrace
DT
$12.1B
$417K 0.02%
7,680
-28
-0.4% -$1.53K
UNM icon
371
Unum
UNM
$13.8B
$415K 0.02%
5,684
EW icon
372
Edwards Lifesciences
EW
$47.6B
$413K 0.02%
5,584
+278
+5% +$19.5K
AVTR icon
373
Avantor
AVTR
$7.81B
$409K 0.02%
19,428
-175
-0.9% -$3.94K
OTIS icon
374
Otis Worldwide
OTIS
$27.4B
$409K 0.02%
4,416
+162
+4% +$16.2K
IWP icon
375
iShares Russell Mid-Cap Growth ETF
IWP
$20B
$409K 0.02%
3,225
+420
+15% +$53.4K

Similar funds

Fifth Third Wealth Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Fifth Third Wealth Advisors held 774 positions worth $1.84B, up 13% from $1.63B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Fifth Third Wealth Advisors deployed $186M of net new capital in Q4 2024, opening 76 new positions and adding to 325 existing holdings. Its largest new stake was ServisFirst Bancshares: 8,713 shares worth $738K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was DexCom, an estimated $1.74M trimmed.

  • Fifth Third Wealth Advisors's largest Q4 2024 buy was ServisFirst Bancshares: 8,713 shares worth $738K.
  • Fifth Third Wealth Advisors added most to iShares Core S&P 500 ETF in Q4 2024, an estimated $29.9M increase.
  • Fifth Third Wealth Advisors's biggest Q4 2024 reduction was DexCom, cutting an estimated $1.74M.
  • Fifth Third Wealth Advisors fully exited Elastic in Q4 2024, selling an estimated $1.26M.
  • Fifth Third Wealth Advisors's ten largest holdings make up 45% of its $1.84B portfolio in Q4 2024.
  • Fifth Third Wealth Advisors opened 76 new positions and closed 52 in Q4 2024.
  • Fifth Third Wealth Advisors's portfolio value rose 13% quarter-over-quarter to $1.84B.

Based on Fifth Third Wealth Advisors's 13F filing for Q4 2024, filed 14 Jan 2025.